In other countries
The same active substances on other registers, the same brand first.
- HyperRAB Solution for Infiltration & Intramuscular InjectionSingapore · 300 iu/ml · injection · Grifols Asia Pacific Pte. LTD.Same strength and form
- IZ HRIG 500 Imunoglobulin protiv bjesnoće, ljudski, 500 IU/bočici, otopina za injekcijuCroatia · otopina za injekciju · Imunološki zavod d.d., Rockefellerova 2, Zagreb, HrvatskaSame form
- HyperrabCanada · 300 UNIT / ML · Solution · Grifols Therapeutics LLCSame substance
- KamrabCanada · 150 UNIT / ML · Solution · Kamada LTDSame substance
- KamrabCanada · 150 UNIT / ML · Solution · Kamada LTDSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
U.S. Food and Drug Administration
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions · Added 11 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Rabies immunoglobulin
- Strength
- 300IU/ML
- Dosage form
- Injection
- Route
- Intramuscular
- Register
- United States (FDA)
- Status
- Marketed
- Status in the register
- Licensed / Rx
- Authorised
- 12 Jun 1974
- Registration
- BLA 101144
- Marketing authorisation holder
- Grifols Therapeutics LLC
- Procedure
- 351(a)
- Supply
- Rx